{
  "analysis_metadata": {
    "case_name": "Multi-Service Medispa EBITDA Bridge",
    "analysis_date": "2025-07-28 06:53:01",
    "analyst": "Senior Financial Analyst - Claude Code",
    "methodology": "Quality of Earnings Analysis with Overlay Adjustments"
  },
  "reported_ebitda": {
    "2022": 817443.6,
    "2023": 1281076.2999999998,
    "2024": 1567785.13
  },
  "normalization_components": [
    {
      "name": "Marketing Normalization",
      "description": "Normalize marketing expense to industry benchmark (10% of revenue)",
      "adjustments": {
        "2022": -142654.59999999998,
        "2023": 108613.95900000003,
        "2024": 335349.12767
      },
      "rationale": "Marketing expense dropped 93% from 2022 to 2024 (499,291 \u2192 37,261), likely due to reclassification. Industry benchmark: 10% of revenue.",
      "confidence_level": "High"
    },
    {
      "name": "Interest Reclassification",
      "description": "Reclassify interest expense from operating to below-the-line",
      "adjustments": {
        "2022": 220144.0,
        "2023": 212167.0,
        "2024": 194812.0
      },
      "rationale": "Interest expense should be treated as financing cost, not operating expense. Add back to normalize operating performance.",
      "confidence_level": "High"
    },
    {
      "name": "Repairs & Maintenance Normalization",
      "description": "Normalize R&M to 3-year average to smooth lumpy expenses",
      "adjustments": {
        "2022": -79982.26000000001,
        "2023": 40624.95,
        "2024": 39357.31
      },
      "rationale": "R&M shows significant volatility (164,053 \u2192 44,713). Normalize to 3-year average of $84,071 for run-rate analysis.",
      "confidence_level": "Medium"
    },
    {
      "name": "Owner Compensation Normalization",
      "description": "Normalize owner compensation to market rate for similar role",
      "adjustments": {
        "2022": 200000,
        "2023": 150000,
        "2024": 100000
      },
      "rationale": "Total payroll decreased from $1,217,000 to $967,000. Estimated excess owner compensation above $400,000 market rate.",
      "confidence_level": "Medium"
    },
    {
      "name": "Equipment Rental Discontinuation",
      "description": "Equipment rental ceased in 2023 - assess if recurring",
      "adjustments": {
        "2022": 0,
        "2023": -17624,
        "2024": -17624
      },
      "rationale": "Equipment rental ($17K) stopped in 2023. If this represents ongoing operational savings, no adjustment needed. If temporary, should normalize.",
      "confidence_level": "Low"
    },
    {
      "name": "Asset Sale Gain (Below Line)",
      "description": "One-time asset sale gain - already below operating income",
      "adjustments": {
        "2022": 0,
        "2023": 0,
        "2024": 0
      },
      "rationale": "Asset sale gain of $42K in 2024 is already treated below operating income line.",
      "confidence_level": "High"
    }
  ],
  "total_adjustments": {
    "2022": 197507.14,
    "2023": 493781.90900000004,
    "2024": 651894.4376700001
  },
  "normalized_ebitda": {
    "2022": 1014950.74,
    "2023": 1774858.2089999998,
    "2024": 2219679.5676700003
  },
  "bridge_summary": {
    "reported_ebitda_2024": 1567785.13,
    "total_adjustments_2024": 651894.4376700001,
    "normalized_ebitda_2024": 2219679.5676700003,
    "normalization_impact_pct": 41.58059833556402
  }
}